Published in Pharma Investments, Ventures and Law Weekly, July 17th, 2005
According to a study from the United States, "Hospitalizations account for 41% of the total cost of end-stage renal disease (ESRD) care. Carnitine deficiency is common among dialysis patients, and some studies have shown improvements in anemia, and cardiac and skeletal muscle function upon administration of L-carnitine."
W.H. Kazmi and colleagues of Tufts University wrote, "We hypothesized that L carnitine may be associated with decreased hospital utilization in these patients. The Fresenius Medical Care North America dialysis database was used for this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly